Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Arch Gynecol Obstet ; 303(4): 1009-1016, 2021 04.
Article in English | MEDLINE | ID: mdl-33201374

ABSTRACT

PURPOSE: We aimed to evaluate the protective effect of edaravone on radiation-induced ovarian damage in an experimental rat model. METHODS: Thirty-two Wistar albino female rats were randomly divided into four groups. Group 1: control, no treatment, and radiation was applied throughout the study; Group 2: sham, only radiation was applied; Group 3: 45 mg/kg edaravone and radiation were applied; Group 4: 450 mg/kg edaravone and radiation were applied. Edaravone was administered intraperitoneally 30 min before radiotherapy (5 Gy). Two days after radiation exposure, the rats were sacrificed and the ovaries were removed. Histologic changes under light microscopy and immunoreactivity for anti-caspase-3 were noted and compared between the four groups. RESULTS: There was a statistically significant difference in follicle counts, vascular congestion, edema, cytoplasmic vacuolization, hemorrhage, and interstitial cell degeneration between the groups. Radiation causes deterioration in most histopathological parameters. Administration of edaravone at different doses seems to reverse these alterations and alleviate the injury. Antioxidant defense mechanisms appear to be enhanced by edaravone as shown by histopathologically and decreased apoptosis by reducing the expression of anti-caspase-3 activity as demonstrated immunohistochemically. CONCLUSION: This is the first study evaluating the protective effects of edaravone on radiation-induced ovarian damage. Edaravone decreased the follicular apoptosis and attenuates the radiation-induced ovarian damage in rats.


Subject(s)
Edaravone/therapeutic use , Free Radical Scavengers/therapeutic use , Ovary/radiation effects , Radiation Injuries/prevention & control , Reperfusion Injury/prevention & control , Animals , Disease Models, Animal , Edaravone/administration & dosage , Female , Free Radical Scavengers/administration & dosage , Free Radical Scavengers/pharmacology , Ovary/pathology , Rats , Rats, Wistar , Reperfusion Injury/pathology
2.
Low Urin Tract Symptoms ; 8(2): 120-4, 2016 May.
Article in English | MEDLINE | ID: mdl-27111624

ABSTRACT

OBJECTIVE: Lower urinary tract symptoms (LUTS) can frequently be seen in pregnant women. Pregnancy and delivery have been considered as risk factors in the occurrence of pelvic floor dysfunction and determinants of LUTS. The main associated risk factor is parity. In the present study, we aim to determine the frequency of LUTS and urinary incontinence (UI) during pregnancy and the associated risk factors. METHODS: This prospective study was carried out in a total of 250 women during their 28- and 40-gestational week checks. The Urinary Distress Inventory-6, the Incontinence Impact Questionnaire-7, and International Consultation on Incontinence Questionnaire-Short Form were used to determine LUTS and its effect on quality of life. RESULTS: The mean age and gestational age of the participants were 29.41 ± 5.70 year (range 18-44) and 35.45 ± 2.98 weeks (range 28-40), respectively. The prevalence of LUTS was 81.6%. The prevalence of UI during pregnancy was 37.2%. Stress urinary incontinence, urge urinary incontinence and mixed urinary incontinence were diagnosed as 15.6, 4.8 and 16.8%, respectively. We found that advanced age, smoking and multiparity were risk factors associated with incontinence. Incontinence reduced pregnant women's quality of life. CONCLUSIONS: Lower urinary tract symptoms are commonly seen among pregnant women and these symptoms negatively affect the quality of life of pregnant women. Advanced age, smoking and multiparity were risk factors associated with urinary incontinence and LUTS. Obstetricians should be on the lookout for individual urological problems in pregnancy. Resolving any urological issues and cessation of smoking for the affected individuals will help alleviate the problem.


Subject(s)
Lower Urinary Tract Symptoms/epidemiology , Pregnancy Complications/epidemiology , Urinary Incontinence/epidemiology , Adolescent , Adult , Cross-Sectional Studies , Female , Humans , Parity , Pregnancy , Pregnancy Outcome , Prospective Studies , Risk Factors , Socioeconomic Factors , Turkey/epidemiology , Young Adult
3.
J Matern Fetal Neonatal Med ; 29(4): 629-32, 2016.
Article in English | MEDLINE | ID: mdl-25708489

ABSTRACT

OBJECTIVE: The aim of this study was to evaluate maternal neutrophil gelatinase-asssociated lipocalin (NGAL) levels and fetal renal artery (fRA) Doppler flow indices in pregnant women fasting in Ramadan in respect of dehydration in long hot summer days as a marker of hypoperfusion and early renal injury. METHODS: A cross-sectional observational study was carried out at a University Hospital. Fasting pregnant women and non-fasting age, gravidity and gestational age-matched women were evaluated for hematologic, blood biochemistry and urine parameters in the first and fourth weeks of the Ramadan. Umbilical artery and fRA Doppler flows were studied in each evaluation. RESULTS: Blood urea nitrogen, potassium and hematocrit levels, blood and urine NGAL levels were significantly higher, and fRA Doppler indices increased in fasting women (p < 0.05) during the second visit in the last week of the Ramadan, while non-fasting women had no significant alterations in each evaluation (p > 0.05). CONCLUSIONS: Adequate maternal vascular volume is essential for the maintenance of healthy pregnancy. Fasting during the long and hot summer days leads to fluid deprivation and dehydration which was found to be related to subclinical maternal renal dysfunction and increased fRA Doppler indices.


Subject(s)
Acute-Phase Proteins/urine , Dehydration/physiopathology , Fasting/physiology , Lipocalins/blood , Lipocalins/urine , Pregnancy Complications/physiopathology , Proto-Oncogene Proteins/blood , Proto-Oncogene Proteins/urine , Renal Artery/diagnostic imaging , Adult , Blood Flow Velocity/physiology , Blood Urea Nitrogen , Cross-Sectional Studies , Fasting/adverse effects , Female , Hematocrit , Hot Temperature , Humans , Islam , Lipocalin-2 , Matched-Pair Analysis , Potassium/blood , Pregnancy , Turkey , Ultrasonography, Doppler , Ultrasonography, Prenatal , Umbilical Arteries/diagnostic imaging
4.
Gynecol Obstet Invest ; 81(1): 47-53, 2016.
Article in English | MEDLINE | ID: mdl-26159359

ABSTRACT

AIM: To evaluate the antioxidant effects of thymoquinone (TQ) and to investigate the biochemical, histopathological and immunohistochemical changes in experimental rat ovarian torsion. METHODS: A total of 48 female adult rats were used in this study and randomly divided into 7 groups: (1) sham operation; (2) bilateral 3-hour ovarian ischemia; (3) 3-hour ischemia and 3-hour reperfusion; (4) and (5) rats were administered 20 and 40 mg/kg of TQ, respectively, before 0.5 h of ischemia, and then 3 h of ovarian ischemia was applied; (6) and (7) 3-hour ovarian ischemia was applied; 2.5 h after the induction of ischemia, rats were administered the same doses of TQ; at the end of 3 h of ischemia, a 3-hour reperfusion was applied. Histologic changes under light microscopy, immunoreactivity for anticaspase-3 and serum levels of malondialdehyde, interleukin-6, catalase and glutathione peroxidase were noted and compared between the 7 groups. RESULTS: Ischemia and ischemia/reperfusion cause a deterioration of biochemical and histopathological parameters. Administration of TQ seems to reverse these alterations and alleviate the injury. Antioxidant defense mechanisms appear to be enhanced by the administration of TQ. CONCLUSION: TQ at different doses attenuates ovarian ischemia and ischemia/reperfusion injury in rats.


Subject(s)
Benzoquinones/pharmacology , Ischemia/therapy , Ovarian Diseases/therapy , Reperfusion Injury/therapy , Animals , Benzoquinones/administration & dosage , Disease Models, Animal , Female , Ischemia/prevention & control , Ovarian Diseases/prevention & control , Rats , Rats, Wistar , Reperfusion Injury/prevention & control
6.
Arch Gynecol Obstet ; 290(2): 233-6, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24619190

ABSTRACT

PURPOSE: The aim of our study was to evaluate the platelet function in unexplained recurrent miscarriage and to investigate whether any hematologic changes detectable by simple complete blood count have a diagnostic value for the prediction of unexplained recurrent miscarriage. METHODS: A prospective study based on the comparison of 74 patients with unexplained recurrent first-trimester pregnancy loss with 208 control subjects matched for age. The two groups were compared in terms of platelet indices. RESULTS: There was a significant difference in platelet distribution width in patients with unexplained recurrent miscarriage compared to healthy control subjects. Platelet distribution width values in the patient group were statistically higher (P < 0.001) than the control group. CONCLUSION: Our study provides an evidence that platelet distribution width gradually increases in women with recurrent miscarriage compared to control group. Patients with unexplained recurrent miscarriage have significantly increased platelet aggregation. This data may provide an empirical rationale for the use of anticoagulants in the management of this clinical condition.


Subject(s)
Abortion, Habitual/blood , Blood Platelets/physiology , Abortion, Habitual/drug therapy , Abortion, Habitual/physiopathology , Adult , Anticoagulants/therapeutic use , Biomarkers/blood , Case-Control Studies , Female , Humans , Platelet Function Tests , Predictive Value of Tests , Pregnancy , Pregnancy Trimester, First , Prospective Studies , Risk Factors
7.
Arch Gynecol Obstet ; 289(6): 1171-5, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24464347

ABSTRACT

PURPOSE: To present the outcomes of four cases of cesarean scar pregnancy treated with suction curettage. METHODS: Four patients were ultrasonographically diagnosed with cesarean scar pregnancies treated with suction curettage in a tertiary care center. RESULTS: Serum ß-human chorionic gonadotropin levels ranged between 1,681 and 15,573 mU/mL, gestational sac diameter measured from 10 to 24 mm and scar thickness was between 4.7 and 6.8 mm. All patients underwent suction curettage under general anesthesia with transabdominal ultrasonography guidance. No complications were observed during or after operation. CONCLUSION: Suction curettage is a viable alternative for conservative treatment in selected cases of patients who are diagnosed with CSP early in gestation and who have a myometrial thickness of more than 4.5 mm.


Subject(s)
Cesarean Section/adverse effects , Cicatrix/complications , Pregnancy, Ectopic/surgery , Vacuum Curettage , Adult , Anesthesia, General , Blood Loss, Surgical , Chorionic Gonadotropin, beta Subunit, Human/blood , Early Diagnosis , Female , Humans , Pregnancy , Pregnancy, Ectopic/diagnostic imaging , Ultrasonography, Interventional
SELECTION OF CITATIONS
SEARCH DETAIL
...